---
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/292345271.md"
description: "First Tracks Biotherapeutics shares are trading higher after HC Wainwright & Co. maintained its Buy rating on the stock and raised its price target from $30 to $44."
datetime: "2026-07-10T16:34:46.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/292345271.md)
  - [en](https://longbridge.com/en/news/292345271.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/292345271.md)
---

# 

First Tracks Biotherapeutics shares are trading higher after HC Wainwright & Co. maintained its Buy rating on the stock and raised its price target from $30 to $44.

### Related Stocks

- [TRAX.US](https://longbridge.com/en/quote/TRAX.US.md)

## Related News & Research

- [J.P. Morgan Sticks to Its Buy Rating for First Tracks Biotherapeutics Inc (TRAX)](https://longbridge.com/en/news/287441580.md)
- [Is Wall Street Bullish or Bearish on NXP Semiconductors Stock?](https://longbridge.com/en/news/295558363.md)
- [Baird Just Upgraded First Solar Stock. Here's Why.](https://longbridge.com/en/news/295570823.md)
- ["Deal Shows Real Traction," Says Citizens Analyst as Fermi Stock (FRMI) Soars on First Big Win](https://longbridge.com/en/news/295557690.md)
- [Needham & Company LLC Upgrades First Advantage (NYSE:FA) to Buy](https://longbridge.com/en/news/295132462.md)